2026년 5월 22일 금요일

Korean Stock Morning Briefing May 23, 2026

한국 종목별 히트맵 (20260523 기준)

한국 종목별 히트맵 (20260523 기준)

미국 종목별 히트맵 (20260523 기준)

미국 종목별 히트맵 (20260523 기준)

☀️ KR Dawn Briefing (2026-05-23)

🇺🇸 SPY +0.39% QQQ +0.42% IWM +0.93%

SPY fluctuation 0.60% 🟢 NORMAL

📈 Dominant Sectors: XLV (+1.17%) XLK (+1.00%) XLU (+0.78%)

🎯 Top 3 candidates:

1. Samsung Electronics (005930) [XLK] acc=0.64 corr=1.00 rank=0.783

2. SFA Semiconductor (036540) [XLK] acc=0.62 corr=1.00 rank=0.770

3. Jusung Engineering (036930) [XLK] acc=0.62 corr=1.00 rank=0.769

Reasons for each item:

• Samsung Electronics: XLK strong (+1.00%) + acc=0.64 corr=1.00

• SFA Semiconductor: XLK strong (+1.00%) + acc=0.62 corr=1.00

• Jusung Engineering: XLK strong (+1.00%) + acc=0.62 corr=1.00

💎 Undervalued recommendation (improving earnings + low industry fwd PER):

[XLV → pharma_bio] median fwd PER 30.0

· Pharma Research (214450) PER 21.5 → fwd 16.0 profit improvement +25.5%

· T&L (340570) PER 13.1 → fwd 10.0 profit improvement +23.7%

[XLK → semiconductor] median fwd PER 24.0

· Samsung Electronics (005930) PER 23.6 → fwd 7.0 profit improvement +70.4% ⚠️ TTM bottom and consensus reliability need to be confirmed

· SK Hynix (000660) PER 18.8 → fwd 7.0 profit improvement +62.7%

[XLU → renewable_energy] median fwd PER 12.0

· Korea Gas Corporation (036460) PER 26.1 → fwd 4.0 profit improvement +84.7% ⚠️ TTM bottom and consensus reliability need to be confirmed

No schedule data available.

⚠️ 본 포스트는 투자 참고용 정보이며, 투자 권유가 아닙니다. 모든 투자 판단과 책임은 투자자 본인에게 있습니다.

댓글 없음:

댓글 쓰기

Pharma Research 214450 Analysis: 1Q26 Earnings and Valuation Review 2026

Pharma Research (214450) 1Q26 Earnings Review and Valuation Analysis Pharma Research is an integrated aesthetics company operating across ...